The gender-specific differences in body fat distribution suggest that sex steroids play an important role in regulating body fat distribution. Sex steroids may regulate adipose tissue mass by altering adipocyte number and size. The effects of various sex steroids on in vitro proliferation of preadipocytes from both sc and omental fat depots was investigated in men and women. Abdominal sc and omental preadipocytes from men (n ‫؍‬ 14) and women (8 premenopausal and 7 postmenopausal) were cultured in the presence of 17␤-E2 (10 ؊7 -10 
T HE PATTERN OF distribution of fat has important impli-
cations with regard to the risk of metabolic diseases, such as type 2 diabetes and the development of cardiovascular disease (1) (2) (3) . Accumulation of adipose tissue in the abdominal region (android or central fat), as observed in men, increases the relative risk of these diseases compared with that in women, who tend to accumulate lower body fat in their hips, thighs, and buttocks (gynoid) (3) (4) (5) . The distinct pattern of body fat distribution observed in men and women in addition to the changes in fat distribution observed with hyperandrogenic status, such as polycystic ovary syndrome in women and hypogonadism in men, implicate sex steroids as important candidate factors (5, 6) . Furthermore, disease characterized by abnormalities in aromatase deficiency or aromatase excess syndrome and in physiopathological situations such as pregnancy, postmenopause, and transsexualism are all associated with alterations in fat distribution (7) (8) (9) (10) .
The deposition of adipose tissue in different anatomical regions depends not only on the ability of mature adipocytes to alter their lipid storage capacity, but also on the rate of proliferation of preadipocytes and subsequent differentiation into mature adipocytes (7, 11, 12) . As adipocyte number and size are regulated in a coordinated manner, there is strong evidence that an interaction of a number of hormones may be responsible for regulation of fat mass. Previous studies indicate that growth factors, insulin, glucocorticoids, as well as sex steroids hormones enhance preadipocyte proliferation (11, (13) (14) (15) (16) . Proliferation is dependent on a close relationship between these factors to increase or decrease each parameter and alter cell-cell interactions (17) .
The roles played by sex steroids in the development of adipose tissue mass in humans through precursor cells proliferating until confluence and then differentiating into mature adipocytes are not clearly understood. Previous studies have determined that in human adipose tissue E2 may increase the rate of proliferation in vitro, but there are conflicting data on the differentiation of preadipocytes (10, 15, 16, 18) . In addition, E2 may have a negative effect on the proliferative rate, as previous studies have shown that the downstream metabolite of E2, 2-methoxyestradiol, can inhibit proliferation, although it appears to stimulate adipogenesis (19) . The role of E in mediating changes in adipose tissue mass is also suggested by studies of the ER␣ knockout mouse. The ER␣ knockout mouse is lipodystrophic, with loss of visceral adipose tissue. In human subjects an ER␣ mutation resulting in eunuchoid body fat distribution has been recorded (19a, 20 -22) .
Androgens may also alter adipose tissue mass, but there are few data on their effects on proliferation of preadipocytes. Analysis of the role of androgens in animal studies to date indicates their ability to block both proliferation as well Abbreviations: DMEM/F12, in DMEM/nutrient mix F-12; E1, estrone; TCA, trichloroacetic acid.
as differentiation, as examined in 3T3-L1 and 3T3-F442A preadipocyte cell lines (23) (24) (25) . These effects of androgen on adipose tissue have also been examined in animal castration studies, where castration resulted in an increase in proliferation in both epididymal and perirenal fat. Subsequently, administration of androgens to these cells reversed the effects on proliferation, thereby attenuating the proliferation and restoring the negative effects of androgens (26) .
The aim of the present study was to determine the role of sex hormones in human preadipocyte proliferation in both omental and sc fat and in both men and women. For this assessment we addressed the influence of the active and less active forms of E, E2 and estrone (E1), respectively, as well as the influence of DHT in both primary cultured human sc and omental preadipocytes. Secondly, we examined the influence of sex steroid concentration on the rate of proliferation in samples from both men and women to examine gender-specific effects.
Subjects and Methods Subjects
Subcutaneous and omental abdominal adipose tissues were obtained from 15 female subjects [8 premenopausal 
Adipose tissue isolation
In brief, 2-5 g wet weight fresh abdominal sc and omental adipose tissues were collected. Tissue was initially washed with 1 ϫ PBS containing penicillin (100 U/ml) and streptomycin (100 g/ml). Visible blood vessels and connective tissue were removed, as previously described (27) . All adipose tissue was digested with the same batch of collagenase class 1 (2 mg/ml; Worthington Biochemical Corp., Freehold, NJ) in 1 ϫ HBSS (Life Technologies, Inc., Paisley, UK) for 1 h at 37 C in a water bath and shaken at 100 cycles/min at 37 C. The disrupted tissue was filtered through a double layered cotton mesh, and preadipocyte cells and adipocytes were separated by centrifugation at 360 ϫ g for 5 min. Adipocytes were then discarded, leaving only the preadipocyte population for culture.
Preadipocyte isolation
Pelleted preadipocyte cells were resuspended for 10 min in erythrocyte lysis buffer (0.154 mol/liter NH 4 Cl, 10 mmol/liter KHCO 3 , and 0.1 mmol/liter EDTA) to remove erythrocyte contamination and were centrifuged at 360 ϫ g for 5 min. For assessment of endothelial cell contamination, preadipocyte cells were stained for factor VIII, a known marker of endothelial cells, according to a previously described method (27) . Preadipocyte cells were plated in tissue culture dishes in DMEM/nutrient mix F-12 (DMEM/F12; Life Technologies, Inc.) medium supplemented with 15% FBS to enable attachment of preadipocytes (27) .
Assessment of proliferation
Two separate assay methods were used to determine the effect of sex steroids on the rate of proliferation in preadipocyte cells: DNA assay and thymidine incorporation. Limited analysis of proliferation data was also performed with a third proliferation assay method, sulforhodamine B.
DNA assay
For determination of DNA accumulation during proliferation, a previously described method was adapted and used (28, 29 
Thymidine incorporation
Thymidine incorporation was assessed as detailed by the following method. Isolated preadipocyte cells were resuspended in DMEM/F12 and 15% FCS and plated at a density of 40%. Twenty-four hours postplating the cells, each well containing cells was washed and maintained in DMEM/F12 phenol-red free medium (Life Technologies, Inc.). Treatments were added to each well in triplicate to give final concentrations of E2 (10
Ϫ9 m), and a nonaromatizable androgen, DHT (10
Ϫ7
-10 Ϫ9 m). Preadipocytes were cultured alone with DMEM/F-12 phenol red-free medium as a control. At 24-h intervals, medium was replaced with phenol red-free medium containing [ 
Sulforhodamine B assay
In a modified method described by Papazizis and co-workers (30), preadipocytes were assessed for rate of proliferation by sulforhodamine B assay. Preadipocytes were separated as outlined previously and cultured with or without treatments for 6 -48 h. At each time point (6, 24, or 48 h), ice-cold TCA (6%) was layered over the preadipocytes, with incubation at 37 C for first hour and at 4 C for the second hour. After this, medium and TCA were removed, and plates were washed with PBS. Subsequently, plates were washed in excess water five times, with plates drying between each wash. Plates were finally blotted and airdried at room temperature for 30 -60 min. Sulforhodamine B [0.4% (wt/vol) in 1% acetic acid] was aliquoted into each well and incubated at 37 C for 1 h, with plates subsequently washed with excess acetic acid (1%). Photographs of the preadipocyte cells were taken at a magnification of ϫ400. Unbuffered Tris base (10 mm) was added to each well, and color was allowed to develop. The absorbencies of the samples were read at 540 nm on a spectrophotometer.
Statistical analysis
Statistical analysis was undertaken using ANOVA for analysis of control vs. treatment groups for either men or women. To compare the significance of different treatments between men and women, unpaired t tests were used. Data are presented as the mean Ϯ sem.
Results

Effect of E2 on proliferation in sc preadipocytes cells
In preadipocyte cells from women, maximal proliferation occurred in cells treated with 10 Ϫ7 m E2 between 24 -48 h (48-h DNA assay: control, 12.4 Ϯ 1.3 mol/g; 10 Ϫ7 m E2, 17.5 Ϯ 1.7 mol/g; P ϭ 0.028; Fig. 1A Fig. 2A ). Increases in proliferation were also noted with 10 Ϫ8 and 10 Ϫ9 m E2-treated sc preadipocytes from women, but not to the same extent as that observed with 10 Ϫ7 m E2 (Figs. 1A and 2A ). Separate analysis of the effect of menopausal status on proliferation rate with respect to E2 showed no significant differences.
Assessment of proliferation in sc preadipocytes cells from men indicated that in the DNA assay 10 Ϫ7 m E2 increased the rate of proliferation, with maximal proliferation observed at 48 h (48-h DNA assay: control, 10.9 Ϯ 1.3 mol/g; 10 Ϫ7 m E2, 17.1 Ϯ 1.8 mol/g; P ϭ 0.017; Fig. 1B 2B ). The administration of 10 Ϫ8 and 10 Ϫ9 m E2 to the preadipocytes from men also increased their rate of proliferation above the control value for both the 24 and 48 h points.
Comparative analysis of the effect of E2 treatment on the rate of proliferation of sc preadipocyte cells between men and women
Examination of DNA content indicated that in both males and females, E2 (10 Ϫ7 -10 Ϫ9 m) significantly increased the rate of proliferation over the 72-h period compared with the control value. The maximal effect of E2 (10 Ϫ7 m) on proliferation was observed at 24 h in sc preadipocytes from women and at 48 h in sc preadipocytes from men. Direct comparison of the effect of E2 (10 Ϫ7 m) treatment on the proliferation rate between these time points determined significant differences in response to E2 treatment in women compared with men (men vs. women, DNA assay, 24 h point, P ϭ 0.014; DNA assay, 48 h point, P ϭ 0.038; Fig. 1, A and B) .
In cells treated with lower concentrations of E2 (10 Ϫ8 -10 Ϫ9 m) an increase in the rate of proliferation, as measured by DNA content, was observed, but no changes with respect to gender were found (Fig. 1, A and B) . Assessment of the effect of E2 on the rate of proliferation by measuring [ 3 H]thymidine content compared with the control value demonstrated a pattern similar to that observed in DNA content assays (data not shown). It should also be noted that the rate of proliferation had declined in both male and female preadipocytes by 72 h, and there were no significant differences between the rate of proliferation in any treated or untreated cells after 96 h (data not shown).
Sulforhodamine B assessment of proliferation
The effect of E2 on the rate of proliferation was also measured qualitatively and quantitatively by a sulforhodamide B assay in both male and female sc preadipocyte cells. Sulforhodamine B analysis of sc preadipocytes from women treated with 10 Ϫ7 m E2 compared with those from men confirmed that the maximal rate of proliferation occurred around the 24 h point for women compared with controls (mean Ϯ sem: 24 h control, 1.0 Ϯ 0.0; male, 10 Ϫ7 m E2, 1.63 Ϯ 0.21; female, 10 Ϫ7 m E2, 1.93 Ϯ 0.43; P ϭ 0.032), whereas the maximal rate of proliferation was confirmed to be 48 h for preadipocytes from men. Sulforhodamine B analysis of preadipocytes from men treated with E2 determined that the maximal rate of proliferation occurred later, at 48 h. To confirm that maximal rates of proliferation at 24 h were not due to inconsistencies in seeding, rates of proliferation were assessed at 1 and 6 h by measuring [
3 H]thymidine incorporation. The results indicate that the rate of proliferation between 6 and 24 h increased due to the mitogenic activity of E2 on preadipocytes (Fig. 2, A and B, and Fig. 3A) .
Effect of E2 on proliferation in omental preadipocytes cells
In omental preadipocytes from women treated with E2 (10 
Comparative analysis of E2 treatments on rate of proliferation of omental preadipocyte cells in men and women
In omental preadipocyte cells from men and women, analysis of DNA content determined that E2 (10 Ϫ7 -10 Ϫ9 m) increased the rate of proliferation over the 72-h period compared with the control value, with a maximal effect on the rate of proliferation observed with 10 Ϫ7 m E2 (Fig. 1C) . The maximal effect of E2 (10 Ϫ7 m) on proliferation was observed at 48 h in omental preadipocytes from females and at 72 h in omental preadipocytes from males. Direct comparison of E2 (10 Ϫ7 m) treatment on the proliferation rate between these time points determined significant differences in response to the E2 treatments in women compared with men (men vs. women, DNA assay, 48 h point, P ϭ 0.0007; DNA assay, 72 h point, P ϭ 0.048; Fig. 1, C and D) .
Omental preadipocyte cells treated with lower concentrations of E2 (10 Ϫ8 -10 Ϫ9 m) also increased the rate of proliferation, as measured by DNA content and [ 3 H]thymidine uptake; however, no significant differences in the rate of proliferation were observed between men and women ( Fig.   FIG. 2 . Assessment rate of proliferation as measured by 3 H-thymidine uptake in female (A, 1) and male (B, p) sc preadipocyte cells. Subcutaneous preadipocyte cells were treated with E2 (10 Ϫ7 M) measured over time (1-72 h). Thymidine incorporation is expressed as a measure of disintegrations per minute (DPM) mean Ϯ SEM. For each graph statistical analysis compared each control (Ⅵ) and E2 treatment at the same time point (1-72 h) by unpaired t test (**, P Ͻ 0.01; ***, P Ͻ 0.001).
FIG. 3. Assessment of rate of proliferation as measured by
3 H-thymidine uptake in female (A, 1) and male (B, p) omental preadipocyte cells. Omental preadipocyte cells were treated with E2 (10 Ϫ7 M) measured over time (1-72 h). Thymidine incorporation is expressed as a measure of disintegrations per minute (DPM) mean Ϯ SEM. For each graph statistical analysis compared each control (Ⅵ) and E2 treatment at the same time point (1-72 h) by unpaired t test (*, P Ͻ 0.05; **, P Ͻ 0.01).
1, C and D; corresponding [
3 H]thymidine data not shown). Menopausal status also did not affect the rate of proliferation when subgroups were compared.
Effect of E1 on proliferation in sc and omental preadipocyte cells
The effect of E1 on the rate of proliferation was assessed by both DNA content and [ 3 H]thymidine uptake. Although both control cells and cells treated with E1 (10 Ϫ7 -10 Ϫ9 m) proliferated, there was no significant effect of E1 to enhance proliferation compared with control (Table 1;  corresponding [ 3 H]thymidine data not shown). In addition, no significant effect was observed between sites or in similarly treated preadipocytes from men and women. Also, menopausal status did not significantly affect the rate of proliferation.
Effect of DHT on proliferation in sc and omental preadipocyte cells
The rate of proliferation was again assessed by DNA content and [ 3 H]thymidine incorporation. It was observed that DHT (10 Ϫ7 -10 Ϫ9 m) did not alter the proliferation of preadipocytes compared with that in controls ( Table 2; [ 3 H]thymidine data not shown). It was also noted that no significant effect was observed between sites or between preadipocyte cells from men and women. In addition, changing menopausal status had no significant effect on the rate of proliferation.
Discussion
The increase in adipose tissue mass observed in both lean and obese individuals is due to a concurrent increase in preadipocyte number and mature adipocyte mass through an increase in the volume of cells (31) . This increase in adipose tissue mass is enhanced by numerous growth factors, hormones, and cytokines that influence adipocyte number via an increase in the rate of proliferation in preadipocytes, with an additional effect on subsequent differentiation of the cells into mature, lipid-filled adipocytes. Our study addressed the roles of sex steroids on the rate of proliferation in human cultured preadipocytes. This is the first study to Ϫ9 M) on proliferative rate, measured by a DNA assay in subcutaneous (Sc) and omental (Om) preadipocytes (pa) isolated from female (n ϭ 15) and male (n ϭ 14) abdominal whole adipose tissue. Proliferative rate is expressed as DNA content measured as mol/g mean Ϯ SEM. For each site (Sc, Om) statistical analysis compared significance between each control and E 1 treatment for the same time point using an unpaired t test.
examine the effects of varying concentrations of E2, E1, and DHT on the human preadipocyte proliferative rate in both sexes and in the two major adipose tissue depots.
Using two sensitive methods to measure proliferation we demonstrated that E2 increased the rate of proliferation in preadipocytes, with a maximal effect observed at the highest concentration of E2. Two independent proliferation assay methods were used to evaluate and confirm our results. Although the DNA assay is a more sensitive method for assessment of proliferation, thymidine incorporation data confirmed our initial findings. In addition, confirmation by thymidine incorporation studies demonstrated that E2 affected the rate of proliferation in a gender-and site-specific manner. In sc preadipocyte cells from women, treatment with E2 (10 Ϫ7 m) induced the maximal rate of proliferation by 24 h, with the resulting rate of proliferation almost double that in the controls (as assessed by [ 3 H]thymidine incorporation). This rate of proliferation was maintained for a further 24 h. In male treated sc preadipocyte cells, however, E2 (10 Ϫ7 m) had a reduced effect over the same 24-h period. In male preadipocytes treated with E2 the rate of proliferation was stimulated compared with the control value, with an approximate 27% rise compared with an almost 50% increase observed in the female sc preadipocytes. The rate of proliferation of male preadipocytes eventually matched that of female preadipocytes by the 48-h point. Investigation of the effect of E2 on omental preadipocyte cells by both DNA assay and thymidine uptake demonstrated a similar gender-specific pattern on the rate of proliferation E2 (10 Ϫ7 m) treatment. As shown in the proliferation studies with the sc preadipocytes, omental preadipocyte cells from females were more responsive to E2 than the equivalent male E2-treated omental preadipocyte cells. This heightened response to E2 in women may be due to previous exposure of the cell to E2 in vivo. The omental preadipocyte cells from females treated with E2 maximally proliferated by 48 h, whereas omental preadipocyte cells from males maximally proliferated 24 h later at 72 h.
The effect of E2 on human sc preadipocyte proliferation was first documented by Roncari and colleagues (15) , who demonstrated that E2 (10 Ϫ8 m) stimulated the proliferative rate. The doses used in Roncari's experiment and in this study were chosen to reflect the high local concentrations of E2 to which preadipocytes are exposed within adipose tissue (32) . However, as both preadipocytes and mature adipocytes produce and secrete sex steroids that act in a paracrine and intracrine manner, local concentrations of sex steroids may be greater than circulating levels (32) . However, the experiments by Roncari failed to include a study of sc preadipocytes; therefore, the present gender-specific findings were not observed. Our studies largely support Roncari's early findings. However, as our proliferation data demonstrate, although the rate of proliferation was increased, there was no gender-specific pattern at either 10 Ϫ8 or 10 Ϫ9 m E2. Analysis of the effect on proliferation induced by 10 Ϫ7 m E2 in omental preadipocytes, however, suggested gender-specific effects. These effects may not have been previously observed in the Roncari study, because omental preadipocytes were collected from a relatively small number of subjects (10 in all), whereas this study used a total of 29 preadipocyte samples, with both adipose tissue depots examined. Additionally, the use of FCS in some of the previous studies may have obscured the gender-specific effects (15) . Studies investigating the influence of E2 on rat preadipocytes suggested a gender-specific effect of E2. In preadipocytes from female rats, E2 (10 Ϫ7 m) demonstrated an increase in the rate of proliferation by 50% compared with the control value, whereas treated preadipocytes from male rats failed to be affected by the E2 treatment (16) .
E2 demonstrated adipose tissue depot-specific effects in addition to the influence of gender. E2 (10 Ϫ7 m) treatment stimulated a more rapid rise in proliferation in sc preadipocytes compared with omental preadipocytes for both sexes. It should also be noted that the gender-and depot-specific effects on proliferation were not associated with any changes with adiposity, as there were no significant differences between men or pre-and postmenopausal women.
The relative alteration in proliferation identified between both the adipose tissue sites and between the sexes may result from gender-and depot-specific differences at the level of the receptors. Previous human studies have shown that although women have similar E-binding capacity in sc and omental adipose tissues, men have a higher E-binding capacity in sc adipose than in omental adipose tissue (32) . These data suggest a possible mechanism for at least sc preadipocytes from males proliferating at a higher rate than omental preadipocytes in response to E2. In addition, the binding study data and previous ER studies have not determined a gender-specific differences in receptor number (32, 33) . However, it is important to stress that studies of the effect of regulation of sex steroids on altering fat distribution may be more revealing than identifying male and female receptor density alone in vivo (9, 34, 35) . Recent studies by this group have addressed the role of E2 concentration on ER density and reported that E2 can differentially regulate both ER␣ and ER␤ protein expression in a dose-dependent manner in human sc and omental preadipocytes (36, 37) . Although no gender-specific E2 regulation of ER was addressed, these studies indicate that analysis of both ER␣ and ER␤ subtype function are required as well as analysis of both male and female ER regulation during proliferation in sc and omental preadipocytes.
Analysis of the effect of E1 on the proliferative rate revealed that although downstream metabolites of E2 such as 2-methoxyestradiol may affect proliferation, as detailed in previous studies, E1 itself had no apparent effect on prolif- 
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Ϫ9 M) on proliferative rate, measured by a DNA assay in subcutaneous (Sc) and omental (Om) preadipocytes (pa) isolated from female (n ϭ 15) and male (n ϭ 14) abdominal whole adipose tissue. Proliferative rate is expressed as DNA content measured as mol/g mean Ϯ SEM. For each site (Sc, Om), statistical analysis compared significance between each control and DHT treatment for the same time point using an unpaired t test.
eration (19) . Preadipocytes treated with the weakly active E, E1, increased proliferation in a similar manner as in controls, with no effect observed for dose, adipose tissue site, or gender.
DHT had no apparent effect on the proliferative rate compared with that in controls, and the rate of proliferation was unaffected by dose, adipose tissue site, or gender. Although no previous studies in human subjects have examined the role of androgens in preadipocyte proliferation, previous rat studies reported that T, DHT, dehydroepiandrosterone, androstanediol, and androstenediol given at low concentrations (10 Ϫ7 m) failed to affect preadipocyte proliferation (16) . By contrast, other studies show that DHEA induces antimitogenic effects when administered in high micromolar concentrations to 3T3-L1 cells or to preadipocyte cells from rats and pigs (24, 25) .
Our study demonstrates that E2 in vitro is able to modulate human preadipocyte proliferation in a gender-and site-specific pattern. Preadipocyte cells from females treated with E2 appear more responsive to a rise in the rate of proliferation than those from men. The present findings also suggest that the weak E, E1, does not influence the proliferative rate, with similar findings observed for DHT. In conclusion, although androgens may alter adipose tissue mass, as shown by in vivo studies, nonaromatizable androgens appear not to alter the proliferative rate as a mechanism in human abdominal preadipocyte cells in vitro (9, 22) . This study demonstrates that the local E2 concentration within adipose tissue may represent one potential mechanism for the regulation of regional adipose tissue accumulation in human preadipocytes by altering the rate of proliferation and, hence, number in a gender-and site-specific pattern.
